Bacillus clausii + Oral Rehydration Therapy
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acute Gastroenteritis
Conditions
Acute Gastroenteritis
Trial Timeline
Jul 1, 2014 → Jan 1, 2016
NCT ID
NCT02169817About Bacillus clausii + Oral Rehydration Therapy
Bacillus clausii + Oral Rehydration Therapy is a approved stage product being developed by Sanofi for Acute Gastroenteritis. The current trial status is completed. This product is registered under clinical trial identifier NCT02169817. Target conditions include Acute Gastroenteritis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02169817 | Approved | Completed |
Competing Products
20 competing products in Acute Gastroenteritis